Schedule 13G ownership disclosure
Petros Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 71678J100
Event date: 2021-10-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,016,231
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-130310
- Form type
- SC 13G
- Filer
- HAYWOOD GEORGE WEAVER
- CIK
- CIK 1000514
- Filed
- Oct 27, 2021
- Reporting period
- Oct 19, 2021
- Description
- Schedule 13G beneficial ownership